This suggests that the explanation for the elevated IL-6 and IL-10 may be more complex than a simple increase in receptor expression; instead, there may be more subtle changes in the downstream regulation of TLR5 signalling in RA monocytes. This evidence concerns the gene IL10 and rheumatoid arthritis.